Document Type
Book Chapter
Abstract
This chapter is focused on radiobiological aspects at the molecular, cellular, and tissue level which are relevant for the clinical use of ionizing radiation (IR) in cancer therapy. For radiation oncology, it is critical to find a balance, i.e., the therapeutic window, between the probability of tumor control and the probability of side effects caused by radiation injury to the healthy tissues and organs. An overview is given about modern precision radiotherapy (RT) techniques, which allow optimal sparing of healthy tissues. Biological factors determining the width of the therapeutic window are explained. The role of the six typical radiobiological phenomena determining the response of both malignant and normal tissues in the clinic, the 6R's, which are Reoxygenation, Redistribution, Repopulation, Repair, Radiosensitivity, and Reactivation of the immune system, is discussed. Information is provided on tumor characteristics, for example, tumor type, growth kinetics, hypoxia, aberrant molecular signaling pathways, cancer stem cells and their impact on the response to RT. The role of the tumor microenvironment and microbiota is described and the effects of radiation on the immune system including the abscopal effect phenomenon are outlined. A summary is given on tumor diagnosis, response prediction via biomarkers, genetics, and radiomics, and ways to selectively enhance the RT response in tumors. Furthermore, we describe acute and late normal tissue reactions following exposure to radiation: cellular aspects, tissue kinetics, latency periods, permanent or transient injury, and histopathology. Details are also given on the differential effect on tumor and late responding healthy tissues following fractionated and low dose rate irradiation as well as the effect of whole-body exposure.
DOI
10.1007/978-3-031-18810-7_5
Recommended Citation
Sminia, P., Guipaud, O., Viktorsson, K., Ahire, V., Baatout, S., Boterberg, T., Cizkova, J., Dostál, M., Fernandez-Palomo, C., Filipova, A., François, A., Geiger, M., Hunter, A., Jassim, H., Edin, N. F. J., Jordan, K., Koniarová, I., Selvaraj, V. K., Meade, A. D., Milliat, F., Montoro, A., Politis, C., Savu, D., Sémont, A., Tichy, A., Válek, V., & Vogin, G. (2023). Clinical Radiobiology for Radiation Oncology. https://doi.org/10.1007/978-3-031-18810-7_5
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publication Details
https://doi.org/10.1007/978-3-031-18810-7_5